Key takeaways

  • Non-stimulant ADHD support: Onyda XR (clonidine) is a once-daily, extended-release liquid medication designed to help children manage hyperactivity, impulsivity, and inattention associated with ADHD.
  • Flexible treatment options: It can be used alone or with a stimulant, providing a steady release of medication that works through the night and into the next day.
  • Easy liquid dosing: Taken once daily at bedtime, this orange-flavored oral suspension is a convenient alternative for families who prefer liquid options over traditional pills.

Onyda XR is an extended-release liquid version of clonidine, a generic medication that has been trusted in various medical applications for decades.

Unlike immediate-release versions of clonidine, Onyda XR provides a steady, controlled release of the medication over a 24-hour period.

This extended-release (XR) formula maintains a more consistent level of the medication in the bloodstream. In turn, this helps to avoid peaks or “crashes” that can lead to side effects or a sudden return of ADHD symptoms.

FDA approval and use

In May 2024, the Food and Drug Administration (FDA) approved Onyda XR for the treatment of ADHD in children ages 6 and older. It can be prescribed in two ways:

  • Monotherapy: It can serve as the primary and only medication for ADHD, effectively managing core symptoms for many children.
  • Adjunctive therapy: It can be prescribed in addition to a central nervous system (CNS) stimulant. It can help to “fill in the gaps” if a stimulant isn’t fully managing symptoms like impulsivity, or if a child needs support that lasts longer than a standard stimulant dose.

What is ADHD?

Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder that affects both children and adults.

It’s typically characterized by impulsivity (acting without thinking), restlessness or hyperactivity, or persistent difficulty staying focused, which can impact a person’s daily life and learning.

Visit our dedicated hub for more research-backed information and in-depth resources on ADHD.

Onyda XR belongs to a group of drugs known as alpha-2 adrenergic receptor agonists. It interacts with specific receptors in the brain to help regulate the signals responsible for attention and impulse control.

The exact mechanism of action (how Onyda XR works) isn’t fully understood. However, studies show that it works differently than traditional stimulants like Ritalin (methylphenidate) or Adderall (amphetamine/dextroamphetamine).

Because Onyda XR does not rely on increasing dopamine levels in the same way stimulants do, it provides an essential alternative for:

  • Children who experience “rebound” effects: Some children become very irritable as stimulants wear off, but Onyda XR’s steady release can help smooth out these transitions.
  • Those with stimulant sensitivities: For people who experience high anxiety, significant appetite loss, or tics when taking stimulants, this non-stimulant approach can be much gentler.
  • Evening symptom management: Since it is taken at night, Onyda XR can help bridge the gap for children who struggle with hyperactivity during the evening or early morning hours.

Every child’s body is unique, and side effects can vary. In clinical trials, side effects were generally mild to moderate and often decreased over time as the body acclimated to the medication.

The list below does not include all side effects reported with Onyda XR. For a full list, see the drug’s prescribing information.

Common side effects

When taken as a standalone treatment, you may notice:

  • Sleepiness and fatigue: This is the most common side effect. While the sleepiness usually happens at night, some children may feel a bit sluggish the next morning. If this persists, talk with your child’s doctor about adjusting the timing of the bedtime dose.
  • Irritability: Some children may experience mood shifts or “grumpiness” as they adjust to the medication.
  • Dry mouth: You can help manage dry mouth by encouraging small sips of water or providing sugar-free lozenges.
  • Digestive issues: Constipation is possible, but a diet rich in fiber and fluids can help.

When taken alongside a stimulant for ADHD, the side effects are very similar. Sleepiness and fatigue were still among the most common side effects of Onyda XR. However, dizziness and appetite loss were also commonly reported.

Experiencing side effects? After the Food and Drug Administration (FDA) approves a drug, it tracks and reviews its side effects. If you develop a side effect while taking this medication and want to report it to the FDA, you can visit MedWatch or call 800-FDA-1088.

When to call the doctor

While you monitor your child’s progress, it’s important to contact their doctor or seek immediate medical attention if you notice any of the following symptoms:

SymptomWhat to look for
slow heart rate (bradycardia)significantly slower or irregular pulse
severe dizzinessfeeling faint or actually losing consciousness when standing up
severe mood changesnew or worsening depression, heavy “brain fog,” or extreme irritability that interferes with daily life
skin reactionany new rash, itching, redness, or discoloration

Your child’s doctor will determine the right dose for them based on their specific needs and how they respond to the medication. The information below is an overview of the typical recommended dosages, according to the drug’s prescribing information:

  • Form: Onyda XR comes as an orange-flavored liquid suspension.
  • Strength: It’s available in one strength of 0.1 milligrams (mg) per milliliter (mL).
  • Starting dose: The typical starting dose is 0.1 mg (1 mL) swallowed once daily at bedtime.
  • Dosage titration: Your child’s doctor may choose to increase the daily dose in increments of 0.1 mg (1 mL) each week.
  • Maximum dosage: The maximum recommended dosage for Onyda XR is 0.4 mg (4 mL) once daily at bedtime.

To help ensure the medication is effective and safe, consistency and accuracy are important. Establishing a reliable nightly routine will help your child get the most benefit from their treatment.

Dosing instructions

  • Time of day: Onyda XR should be taken once daily at bedtime. Administering the dose at night allows the peak sedative effects to occur while your child is sleeping. The extended-release formulation ensures that enough medication remains in the system to support focus and behavior the following day.
  • Food and diet: The medication can be taken with or without food.
  • Preparing the liquid form: Because this is an oral suspension, the active ingredients can settle at the bottom over time. It is important to shake the bottle gently but thoroughly before every single dose. Not shaking the bottle can result in your child receiving too little medication at the start of the bottle and too much at the end.

Proper administration tips

  • Equipment: Only use the specific oral dosing syringe that comes with the Onyda XR bottle. Household kitchen spoons vary greatly in size and are not accurate for medical dosing.
  • Positioning and comfort: To prevent choking or spitting, ensure your child is sitting upright or in a slightly reclined, seated position. Avoid giving the medication while they are lying flat in bed.
  • Technique: Tilt the child’s head slightly upward. Place the tip of the oral syringe into the mouth and point it toward the inside of the cheek. This “cheek-aiming” method is safer than pointing it toward the back of the throat, as it reduces the risk of gagging or accidental inhalation of the liquid. Push the plunger slowly, allowing them to swallow naturally.

What if a dose is missed?

If your child misses a bedtime dose, skip it entirely and wait until the following night’s bedtime to resume the schedule.

Do not attempt to give the missed dose in the morning, as this may lead to excessive daytime sleepiness.

Most importantly, never “double up” by giving two doses at once the next night. Doubling the dose can lead to a dangerous drop in blood pressure or heart rate.

Storage and disposal tips

Temperature control: Store the bottle at room temperature, ideally between 20°C and 25°C (68°F to 77°F). Avoid keeping it in a bathroom medicine cabinet where humidity and heat from the shower can degrade the liquid.

Light protection: The active ingredients in Onyda XR are sensitive to light. Always keep the bottle in its original packaging or a dark cupboard.

Disposal: Once you open a new bottle of Onyda XR, discard any remaining liquid after 30 days (for the 30-mL and 60-mL bottles) or 60 days (for the 120-mL bottle). Even if there is plenty of medication left, the preservatives may no longer be effective, and the drug’s potency can change.

To help keep track, you can write the “discard date” clearly on the bottle’s label the moment you open it.

While Onyda XR is a safe and effective treatment for many, it requires careful management to avoid complications related to blood pressure and heart health.

Monitor blood pressure and heart rate

Because clonidine was originally created to treat high blood pressure, Onyda XR can naturally lower blood pressure (hypotension) and slow the heart rate.

  • Symptoms to watch for: Watch for increased dizziness, a pale complexion, or a “fuzzy” feeling in the head, especially when your child stands up quickly from a sitting or lying position.
  • Prevention and hydration: Dehydration can worsen these heart-related side effects. Ensure your child drinks plenty of water throughout the day and stays cool during physical activity or in hot weather, as overheating can lead to fainting spells (syncope).

Never stop suddenly

Your child should not abruptly stop taking Onyda XR. Your child’s body gets used to the way the medication affects their blood vessels and blood pressure. If they stop taking this medication “cold turkey,” they may experience rebound hypertension (a rapid, severe spike in blood pressure).

If you and your child’s doctor decide to stop the medication, it’s important to follow a strict “tapering” plan. This usually involves slowly decreasing the dose (by no more than 0.1 mg every 3 to 7 days) to allow the heart and blood vessels time to adjust. Always talk with your child’s doctor before making any dosage adjustments.

Know the signs of an allergic reaction

While rare, a serious allergic reaction is possible. Before your child starts taking this drug, let their doctor know if they’ve had a previous allergic reaction to any of Onyda XR’s ingredients, including other forms of clonidine.

Seek emergency medical attention if your child experiences:

  • hives
  • rapid swelling of the face, lips, tongue, or throat (angioedema)
  • difficulty breathing or swallowing

For a complete list of Onyda XR’s warnings and precautions, take a look at the drug’s prescribing information.

Onyda XR can interact with other substances in ways that can be harmful or simply make the medication less effective. Be sure to talk with your doctor if any of the following apply to your child:

  • Sedating medications: Use extra caution if your child takes another medication that causes sleepiness, including over-the-counter allergy drugs like Benadryl (diphenhydramine), sleep aids, or prescription muscle relaxants.
  • Blood pressure and heart medications: If your child is taking any other medication for heart rhythm or blood pressure, the combined effect could cause their heart rate to drop to unsafe levels.
  • Alcohol: For older adolescents, it is important to know that alcohol must be avoided completely. Alcohol significantly increases the sedative effects of clonidine, which can lead to severe drowsiness and impaired coordination.
  • Other forms of clonidine: Onyda XR is not interchangeable with other clonidine medications like Catapres or Kapvay on a milligram-for-milligram basis. Each brand-name medication has a different “pharmacokinetic profile” (how the body absorbs and uses the drug). Switching brands without a doctor’s specific guidance can lead to either an overdose or an increased risk of serious side effects.

Understanding the financial aspect of treatment is just as important as the clinical one. As a newer brand-name medication, Onyda XR does not currently have a generic equivalent, so its “list price” may be higher than that of older medications.

Insurance and retail pricing

The out-of-pocket cost for Onyda XR without insurance typically ranges between $500 and $600 for a 30 mL bottle. However, the price you actually pay depends heavily on your insurance provider’s formulary. Many commercial insurance plans cover Onyda XR, often bringing the cost down to a standard copay.

What is a formulary?

A formulary is a list of prescription drugs that a health insurance plan covers. The plan may place covered drugs into different cost-sharing tiers.

Savings and support programs

Tris Pharma, the manufacturer of Onyda XR, offers programs to help make the medication more accessible:

  • The Tris Savings Card: Eligible families with commercial insurance may pay as little as $25 per prescription. This card can be activated online or through your doctor’s office.
  • Cash-paying assistance: Even for families without insurance coverage, drug manufacturers and third-party savings programs often provide discounts that can lower the retail price significantly at participating pharmacies.
  • Patient assistance programs: For families who meet specific income requirements, there may be programs available to receive the medication at no cost. For details, talk with your pharmacist or pediatrician.

Optum Perks is owned by RVO Health. By clicking on this link, we may receive a commission. Learn more.

If Onyda XR isn’t the right fit for your child, there are several other non-stimulant, long-term options your child’s doctor might consider.

FDA-approved non-stimulants for ADHD

  • Intuniv (guanfacine XR): Like clonidine, guanfacine XR is an alpha-2 adrenergic receptor agonist. It is approved for children ages 6 to 17 years old and can be taken once daily in the morning or evening.
  • Strattera (atomoxetine): Strattera is a selective norepinephrine reuptake inhibitor (SNRI). It was the first non-stimulant approved by the FDA for ADHD in children (ages 6 years and older).
  • Qelbree (viloxazine): Qelbree is an SNRI that was approved in 2021 for children ages 6 and older. It comes in a capsule that can be swallowed whole or opened and sprinkled on food.
  • Kapvay (clonidine XR tablets): This is the tablet version of extended-release clonidine. Due to its similarity to Onyda XR, Kapvay typically carries the same potential risks, benefits, and side effects.

Off-label non-stimulant alternatives

Sometimes, a child’s doctor may prescribe a medication “off-label.” This means the FDA has approved the drug for one condition (like depression), but doctors use it to treat another (like ADHD) based on clinical evidence.

  • Wellbutrin (bupropion): While primarily an antidepressant, Wellbutrin is sometimes used off-label for ADHD in children if other treatments have not worked.
  • Tricyclic antidepressants (TCAs): TCAs like nortriptyline or imipramine are occasionally used off-label for ADHD, though they are less common today due to newer options with fewer side effects.
Details
Generic nameClonidine hydrochloride
Primary useADHD symptoms in children (ages 6+)
Dose timingOnce daily at bedtime
FormOrange-flavored liquid solution
Critical safetyNever stop abruptly; it must be tapered
Interaction riskAvoid alcohol and other sedatives
Shelf life30 mL or 60 mL bottle: Discard 30 days after opening

120 mL bottle: Discard 60 days after opening

Onyda XR can be a beneficial addition to an ADHD treatment plan, offering a non-stimulant alternative that helps provide coverage when it is needed most.

By staying informed, following the administration guidelines carefully, and maintaining open communication with your child’s doctor, you can help ensure a safe and successful experience with this medication.

Disclaimer: While Medical News Today strives for factual, comprehensive, and current drug information, this article is not a substitute for a licensed healthcare professional’s expertise. Always consult a doctor before taking or discontinuing any medication. Drug information is subject to change and may not cover all uses, directions, precautions, warnings, interactions, reactions, or adverse effects. The lack of a warning does not guarantee a drug’s safety, effectiveness, or appropriateness for all patients or specific uses. Learn more about our approach to content integrity.